Home › Funds › POSTROCK PARTNERS LLC › TECH

POSTROCK PARTNERS LLC position in TECH

BIO-TECHNE CORP · Health Care

POSTROCK PARTNERS LLC reported holding 21,006 shares of TECH (BIO-TECHNE CORP) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.61% of its reported portfolio and ranking #25 among its reported holdings. POSTROCK PARTNERS LLC has disclosed TECH holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)21.01K sh
Reported value held$1.52M
Portfolio Weight0.61%
First reportedQ4 2024
Last changeHold
Updated2026-11-03

Last updated: 2026-11-03 · Source: SEC EDGAR Form 13F-HR

How POSTROCK PARTNERS LLC's TECH position evolved

POSTROCK PARTNERS LLC first disclosed a stake in TECH in Q4 2024 at 21,170 shares (US$1.5M). Across 8 filings, POSTROCK PARTNERS LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 21,006 shares valued at US$1.5M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 21.17K $1.52M New
Q1 2025 21.17K $1.24M Hold
Q2 2025 21.09K $1.08M Hold
Q3 2025 21.09K $1.17M Hold
Q4 2025 21.09K $1.24M Hold
Q1 2026 21.01K $1.10M Hold
Q2 2026 21.01K $1.48M Hold
Q3 2026 21.01K $1.52M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECH and 13F data

TECH (BIO-TECHNE CORP) is a Health Care company. 29 other funds we track also report a position in TECH — the largest reported positions include HBK INVESTMENTS L P (US$482.2M), Ruane Cunniff & Goldfarb (Sequoia) (US$236.6M), SNYDER CAPITAL MANAGEMENT L P (US$223.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECH

All TECH fund holders →

FAQ

How long has POSTROCK PARTNERS LLC held TECH?

POSTROCK PARTNERS LLC has disclosed TECH holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is POSTROCK PARTNERS LLC's current position in TECH?

As of Q3 2026, POSTROCK PARTNERS LLC holds 21.01K shares of TECH (BIO-TECHNE CORP), valued at $1.52M, representing 0.61% of its reported portfolio and ranking #25.

Has POSTROCK PARTNERS LLC been buying or selling TECH?

In the latest 13F filing (Q3 2026), POSTROCK PARTNERS LLC held unchanged its position in TECH.

Which other funds hold TECH?

Other major institutional holders of TECH include HBK INVESTMENTS L P, Ruane Cunniff & Goldfarb (Sequoia), SNYDER CAPITAL MANAGEMENT L P, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.